Search results for #COVID19nCancer
#Cancer patients have a 2-fold higher risk of dying from #COVID19 than the general US population, data suggest. From @JNCI_Now and @TheLancetOncol. brnw.ch/21wJptn #COVID19nCancer
BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 ash.confex.com/ash/2022/webpr… #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6
Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment [Nov 23, 2021] @ovanoekelen Abstract 882 #ASH21 ashpublications.org/blood/article/… #COVID19Vaccine #COVID19nCancer #mmsm cc @COVID19nCCC
Efficacy of @BioNTech_Group @pfizer BNT162b2 mRNA #COVIDVaccine in Pts w/ CLL [6/10/21] @herishanu et al @BloodJournal ow.ly/UZSf50F7OJM #NCT04746092 #COVID19nCancer #CLLsm #leusm #CCC19 #COVID19 @COVID19nCCC Ab response: Remission 79.2%; Tx-naive 55.2%; Active Tx 16.0%
Seroconversion rates following COVID-19 vaccination amongst patients with cancer [Jun 5, 2021] @asthakkar15 et al. @DrSteveMartin @Cancer_Cell ow.ly/59Vf50F9HRR #COVID19Vaccine #COVID19nCancer #CCC19 #leusm #lymsm #mmsm #mpnsm cc @COVID19nCCC HT @jrgralow
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma [April 19, 2021] Bird et al. @TheLancetHaem ow.ly/ZZsA50FpeyE #mmsm #COVID19Vaccine #COVID19nCancer #CCC19 @COVID19nCCC
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera @peters_solange et al @gary_lyman @hemoncwarner @CD_AACR ow.ly/e5Fl30qZTno #AACRCovid #COVID19nCancer n=2186
Covid‐19 and Myeloma: what are the implications for now and in the future? [May 19, 2020] Freeman & @jmikhaelmd Br J Haematol ow.ly/wLDV30qKlDc #mmsm #IDonc #CCC19 #COVID19nCancer #2019nCoV #COVID19 @COVID19nCCC
Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer
Real World Third COVID19 Vaccine Dosing and Antibody Response in Patients with Hematologic Malignancies [Jul 18, 2022] @mtmdphd , Hallmeyer, @vrepublic , Liao, @mullane_michael @scmedlin , Copeland, @JimW9200 @JPCRR institutionalrepository.aah.org/jpcrr/vol9/iss… #COVID19nCancer #COVID19Vaccine #IDonc
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study [Feb 20, 2024] @ClCastellano et al. @JournalCancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CCC19 #COVID19nCancer #COVID19 @COVID19nCCC #camets
Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (#CCC19) Study [Feb 14, 2022] Satyanarayana et al. @DFarmakiotis @COVID19nCCC Open Forum Infectious Diseases ow.ly/uHAz50HUZav #COVID19nCancer #IDonc #COVID19
Five Questions With: Sanjay Mishra @Ecquis [Nov 26, 2023] By @Katie_c912 @ProvBusNews pbn.com/five-questions… #CCC19 @COVID19nCCC #COVID19nCancer #COVID19Vaccine @DrDonnaRivera @NCIJBSloan
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
COVID‐19 vaccine effectiveness in patients with hematologic malignancy [May 18, 2022] @DrDimpyShah @Dr_Pankil_Shah @mtmdphd Transplant ID onlinelibrary.wiley.com/doi/10.1111/ti… #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc
Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology ow.ly/RSt450E2I9U #CCC19 #COVID19nCancer
COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc ow.ly/8fyz50G38Y4 #COVID19nCancer #CCC19 @COVID19nCCC
Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer ow.ly/wuyD30qzDyS #CCC19 #COVID19nCANCER @COVID19nCCC
